The life science industry is all hands on deck in the race to develop vaccines, therapies and diagnostics in the fight against coronavirus. But while some prosper, many in the sector are forced to halt clinical trials and mothball labs

Action plan includes clinical trials funding and new research task force to share COVID-19 knowledge

The EU has mobilised fairly quickly, with a good mix of funding for research on the coronavirus pandemic, says Matthias Kleiner, president of the Leibniz Association

The COVID-19 pandemic provides a stark illustration of why we need effective tools for sharing health data in Europe, say four MEPs

The global pandemic is brutally exposing how reliant the EU – and the rest of the world – is on high quality research, collaboration and data sharing. These lessons must be applied in Horizon Europe  

The working relationship with the European Research Council’s star appointment was difficult from the off, but few imagined it would unravel so quickly

Funding vaccine, drug and diagnostic development is the world’s one exit strategy from the pandemic

The Scientific Council of the ERC, the European Commission and Horizon Europe rapporteur Christian Ehler react to Mauro Ferrari's resignation letter published by the Financial Times on Tuesday.

Mauro Ferrari quits after just three months at helm of EU research agency, citing “uncoordinated” COVID-19 response. But MEP Ehler denounces the move as ‘window-dressing’